Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Thousands		12 Months Ended
		Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Total net revenue		$ 429,909	$ 396,289	$ 382,928
Total cost of revenue	[1]	269,954	236,782	233,207
Research and development	[2]	57,752	52,729	49,784
Products
Total net revenue	[3]	214,715	176,647	167,302
Total cost of revenue		127,287	102,100	95,882
Services
Total net revenue	[4]	215,194	219,642	215,626
Total cost of revenue		142,667	134,682	137,325
Revenue from Joint Venture
Total cost of revenue		35,237	13,310	13,174
Research and development		2,336	430
Revenue from Joint Venture | Products
Total net revenue		45,545	12,033	11,202
Revenue from Joint Venture | Services
Total net revenue		$ 10,332	$ 12,360	$ 7,851

[1] Includes cost of revenue from sales to the China joint venture, an equity method investment of $35,237 for the year ended June 30, 2022, $13,310 for the year ended June 30, 2021 and $13,174 for the year ended June 30, 2020, respectively. See Note 13.

[2] Includes chargeback to the China joint venture, an equity method investment related to research and development project of $2,336 and $430 for the year ending June 30, 2022 and June 30, 2021, respectively

[3] Includes sales to the China joint venture, an equity method investment of $45,545 for the year ended June 30, 2022, $12,033 for the year ended June 30, 2021 and $11,202 for the year ended June 30, 2020, respectively. See Note 13.

[4] Includes sales to the China joint venture, an equity method investment of $10,332 for the year ended June 30, 2022, $12,360 for the year ended June 30, 2021 and $7,851 for the year ended June 30, 2020, respectively. See Note 13.